ホーム
マーケット
チャート&アイデア
Algo
ニュース
Store
ブローカー
ダウンロード
経済指標カレンダー
取引シグナル
Webターミナル
「
/
」を入力して検索:@user、$symbol
検索
ログイン
アカウントを作成
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HRMY
#1797
Harmony Biosciences Holdings, Inc. Common Stock
28.540
0
+0.25%
セクター:
ベース:
利益通貨:
日中レンジ
1年のレンジ
1日の変化
+0.25%
月次変化
-24.24%
6か月変化
-7.64%
1年の変化
-7.64%
以前の終値
28.470
0
Open
28.540
0
Bid
Ask
Low
28.540
0
High
28.540
0
ボリューム
110
マーケット
株
ヘルスケア
HRMY
Open full chart
Financials
Overview
明細書
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
57.03 M
57.35 M
57.42 M
57.53 M
57.6 M
57.84 M
—
Valuation ratios
Enterprise value
1.89 B
1.52 B
1.42 B
1.27 B
940.36 M
1.41 B
5.04 B
Price to earnings ratio
18.87
13.71
12.67
10.19
8.67
13.81
45.34
Price to sales ratio
3.42
2.79
2.58
2.38
1.95
2.52
9.44
Price to cash flow ratio
10.63
9.06
8.64
7.09
5.41
6.29
27.43
Price to book ratio
1.1
3.02
0.77
0.67
0.54
2.52
4.49
Enterprise value to EBITDA ratio
8.78
7.12
6.02
4.85
3.53
6.1
20.5
Profitability ratios
Return on assets %
0.05
0.05
0.04
0.04
0.04
0.02
0.14
Return on equity %
0.08
0.08
0.06
0.05
0.06
0.03
0.2
Return on invested capital %
41.64
43.28
36.37
29.77
39.61
19.07
124.81
Gross margin %
77.01
72.97
82.68
80.97
75.09
71.88
310.62
Operating margin %
33.17
27.69
30.45
24.03
27.35
15.82
97.64
EBITDA margin %
36.18
39.38
33.52
26.86
29.77
25.55
115.7
Net margin %
24.78
24.58
24.66
19.84
21.24
9.22
74.97
Liquidity ratios
Quick ratio
3.2
3.27
3.63
3.8
3.72
3.58
14.74
Current ratio
3.24
3.31
3.67
3.84
3.75
3.6
14.86
Inventory turnover
6.81
7.71
4.71
6.11
9.19
11.2
31.21
Asset turnover
0.21
0.21
0.18
0.19
0.21
0.2
0.77
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.18
0.16
0.15
0.14
0.12
0.11
0.52
Long term debt to total equity ratio
0.28
0.25
0.22
0.2
0.18
0.17
0.76
Per share metrics
Operating cash flow per share
1.21
1.31
0.58
1.36
1.85
2.15
5.95
EBIT per share
1.06
0.96
0.96
0.82
1.12
0.66
3.56
EBITDA per share
1.16
1.37
1.06
0.92
1.21
1.06
4.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.06
8.07
8.66
9.67
11.45
13.24
43.04
Net current asset value per share
8.99
10.01
10.98
11.83
14.29
15.49
52.59
Tangible book value per share
8.22
9.43
10.48
11.5
12.6
13.34
47.91
Working capital per share
6.22
6.98
7.99
8.75
10.48
11.19
38.41
Book value per share
10.27
11.39
12.31
13.23
14.22
14.86
54.63
ニュース
BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y
IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress
RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up
Corcept's Q4 Earnings and Revenues Fall Short of Estimates
Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y
Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y
UBS reduce precio objetivo de Harmony Biosciences por entrada anticipada de genérico
UBS recorta el precio objetivo de Harmony Biosciences por entrada anticipada de genérico de Wakix
UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry
Truist reitera mantener en acciones de Harmony Biosciences, fija objetivo de 25 dólares
Truist reitera calificación Hold en Harmony Biosciences, fija objetivo de $25
Truist reiterates Hold on Harmony Biosciences stock, sets $25 target